Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Ingle

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of maytansine in patients with metastatic lung cancerR T Eagan, E T Creagan, J N Ingle, et al.
Cancer|April 15, 1981
Malignant, predominantly lymphocytic thymoma with central and peripheral nervous system metastasesM R Wick, W C Nichols, J N Ingle, et al.
Cancer|July 15, 1987
Pericardial effusion in women with breast cancerM Buck, J N Ingle, E R Giuliani, et al.
Bone Marrow Transplantation|January 10, 2002
Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancerL F Porrata, J N Ingle, M R Litzow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Metaplastic breast cancer: prognosis and response to systemic therapyD Rayson, A A Adjei, V J Suman, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarityW L Lingle, W H Lutz, J N Ingle, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Progress report on a phase II trial of 5-fluorouracil plus citrovorum factor in women with metastatic breast cancerC L Loprinzi, J N Ingle, D J Schaid, et al.
Cancer Treatment Reports|January 1, 1981
Phase II evaluation of PALA and AMSA for patients with disseminated malignant melanomaE T Creagan, D L Ahmann, J N Ingle, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|January 1, 1978
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communicationR T Eagan, J N Ingle, J Rubin, et al.
Cancer Treatment Reports|October 1, 1978
Phase II evaluation of maytansine in patients with metastatic lung cancerR T Eagan, E T Creagan, J N Ingle, et al.
Cancer|April 15, 1981
Malignant, predominantly lymphocytic thymoma with central and peripheral nervous system metastasesM R Wick, W C Nichols, J N Ingle, et al.
Cancer|July 15, 1987
Pericardial effusion in women with breast cancerM Buck, J N Ingle, E R Giuliani, et al.
Bone Marrow Transplantation|January 10, 2002
Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancerL F Porrata, J N Ingle, M R Litzow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Metaplastic breast cancer: prognosis and response to systemic therapyD Rayson, A A Adjei, V J Suman, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarityW L Lingle, W H Lutz, J N Ingle, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Progress report on a phase II trial of 5-fluorouracil plus citrovorum factor in women with metastatic breast cancerC L Loprinzi, J N Ingle, D J Schaid, et al.
Cancer Treatment Reports|January 1, 1981
Phase II evaluation of PALA and AMSA for patients with disseminated malignant melanomaE T Creagan, D L Ahmann, J N Ingle, et al.
Pageof 17